In Brief: Fuisz Technologies
This article was originally published in The Tan Sheet
Executive Summary
Fuisz Technologies: Michael Myers, PhD, to VP-sustained release, directing the Chantilly, Va.-based company's new, separate operating division that focuses on developing sustained-release drug formulations using Fuisz' multiparticulate technology. Myers formerly was head of product development at Elan. He reports to Chairman and CEO Richard Fuisz, MD...